Your browser doesn't support javascript.
loading
Clinical and biomarker factors affecting survival in patients with platinum-sensitive relapsed ovarian cancer receiving olaparib monotherapy: a multicenter retrospective study.
Tashiro, Ryota; Kawazoe, Hitoshi; Mamishin, Kanako; Seto, Keisuke; Udagawa, Ryoko; Saito, Yoshimasa; Hashimoto, Hironobu; Shimoi, Tatsunori; Yonemori, Kan; Yonemura, Masahito; Terakado, Hiroyuki; Nishimura, Takahiro; Kawasaki, Toshikatsu; Furukawa, Tetsuya; Nakamura, Tomonori.
Affiliation
  • Tashiro R; Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan.
  • Kawazoe H; Division of Pharmaceutical Care Sciences, Keio University Graduate School of Pharmaceutical Sciences, Tokyo, Japan.
  • Mamishin K; Division of Pharmaceutical Care Sciences, Keio University Graduate School of Pharmaceutical Sciences, Tokyo, Japan. kawazoe-ht@keio.jp.
  • Seto K; Division of Pharmaceutical Care Sciences, Center for Social Pharmacy and Pharmaceutical Care Sciences, Faculty of Pharmacy, Keio University, Tokyo, Japan. kawazoe-ht@keio.jp.
  • Udagawa R; Department of Pharmacy, National Cancer Center Hospital East, Chiba, Japan.
  • Saito Y; Department of Pharmacy, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.
  • Hashimoto H; Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan.
  • Shimoi T; Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan.
  • Yonemori K; Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan.
  • Yonemura M; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Terakado H; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Nishimura T; Department of Pharmacy, National Cancer Center Hospital East, Chiba, Japan.
  • Kawasaki T; Department of Pharmacy, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.
  • Furukawa T; Department of Pharmacy, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.
  • Nakamura T; Department of Pharmacy, National Cancer Center Hospital East, Chiba, Japan.
Sci Rep ; 13(1): 11962, 2023 07 24.
Article in En | MEDLINE | ID: mdl-37488223

Full text: 1 Database: MEDLINE Main subject: Ovarian Neoplasms / BRCA1 Protein Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Ovarian Neoplasms / BRCA1 Protein Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Year: 2023 Type: Article